Nektar Therapeutics
NKTR
$23.65
Share price
-5.40%
Change (1 day)
1,638.97%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - Net assets
Net assets on the balance sheet as of March 2025 : $13.73 Million USD
According to Nektar Therapeutics
's latest financial reports the company has $13.73 Million USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Nektar Therapeutics - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$60.73 M | -53.63% |
| 2023-12-31 | $$0.13 B | -64.27% |
| 2022-12-31 | $$0.36 B | -46.04% |
| 2021-12-31 | $$0.67 B | -36.92% |
| 2020-12-31 | $$1.07 B | -23.35% |
| 2019-12-31 | $$1.40 B | -18.18% |
| 2018-12-31 | $$1.71 B | 1855.61% |
| 2017-12-31 | $$87.82 M | -0.34% |
| 2016-12-31 | $$88.12 M | 1270.74% |
| 2015-12-31 | $$6.42 M | -82.3% |
| 2014-12-31 | $$36.33 M | -140.41% |
| 2013-12-31 | $-$89.91 Million | -291.21% |
| 2012-12-31 | $$47.01 M | -76.23% |
| 2011-12-31 | $$0.19 B | 118.19% |
| 2010-12-31 | $$90.66 M | -11.43% |
| 2009-12-31 | $$0.10 B | -46.17% |
| 2008-12-31 | $$0.19 B | -11.32% |
| 2007-12-31 | $$0.21 B | -5.56% |
| 2006-12-31 | $$0.22 B | -30.52% |
| 2005-12-31 | $$0.32 B | -30.07% |
| 2004-12-31 | $$0.46 B | 184.63% |
| 2003-12-31 | $$0.16 B | -20.59% |
| 2002-12-31 | $$0.20 B | -23.51% |
| 2001-12-31 | $$0.27 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $6.20 B | 45,081.25% | 🇺🇸 USA |
 Pfizer PFE | $90.63 B | 659,653.97% | 🇺🇸 USA |
 Merck MRK | $48.40 B | 352,207.47% | 🇺🇸 USA |
 Richardson Electronics RELL | $0.15 B | 1,012.97% | 🇺🇸 USA |
 AstraZeneca AZN | $41.13 B | 299,295.84% | 🇬🇧 UK |
 Baxter BAX | $7.05 B | 51,246.63% | 🇺🇸 USA |
 Alkermes ALKS | $1.51 B | 10,902.91% | 🇮🇪 Ireland |
 Johnson & Johnson JNJ | $78.10 B | 568,461.65% | 🇺🇸 USA |